This new deal with Acuity has lots of substance, because it implies that Sayona is not only serious about producing Spodumene next year, but it also provides extra cash to get carbonate/hidroxide rolling, which is where the big money will be. The move suggests that they want to get that first refinery built so they take advantage of the favorable prices and get some independence from Piedmont or arrange a new deal. It make take some time for the market to digest the news, but I think it will eventually, specially with the implied/potential pricing of $0.8 Aussie per share.
Please share if there are other insights or any negatives. Thanks
GLTAH